Perceived Benefits and Harms of Involuntary Civil Commitment for Opioid Use Disorder

Elizabeth A Evans1, Calla Harrington1, Robert Roose1

  • 1Elizabeth A. Evans, Ph.D., M.A., is an Associate Professor of public health at the University of Massachusetts Amherst. She received her B.A. from the University of California San Diego, her M.A. from Indiana University, Bloomington, and her Ph.D. from the University of California Los Angeles Fielding School of Public Health. Dr. Evans researches how health care systems and public policies can better promote health and wellness particularly among individuals at risk for opioid and substance use disorders, mental illness, and infectious diseases. Calla Harrington, M.P.H., M.S.W., L.C.S.W., is a Research Fellow in the Department of Health Policy and Promotion at the University of Massachusetts Amherst. Calla received her M.P.H. in Epidemiology from UMass Amherst, her clinical M.S.W. from Boston University, M.A., and her B.S.W. from Eastern University in St. Davids, PA. Robert Roose, M.D., M.P.H., F.A.S.A.M., is the Chief Medical Officer for Mercy Medical Center and affiliates. Dr. Roose received his M.D. and M.P.H. from the George Washington University School of Medicine and Health Sciences in Washington, DC. He received his B.S. from the University of Illinois at Urbana-Champaign, IL. He serves on the Quality Improvement Council of the American Society of Addiction Medicine and is a key contributor to opioid task forces in Massachusetts. Susan Lemere, M.S.W., L.I.C.S.W., received her M.S.W. from Smith College in Northampton, MA, a M.F.A. from Pine Manor College in Brookline, MA, and a B.A. at UMass Amherst. Currently, she is pursuing her Ph.D. in public health at UMass Amherst. David Buchanan, Dr.P.H., Professor Emeritus at UMass Amherst, received his B.A., his M.P.H., and his Dr.PH., from University of California Berkeley. He is a prominent expert in public health ethics.

Summary

Involuntary civil commitment (ICC) for opioid use disorder (OUD) can prevent overdose but carries ethical risks. Ethical use requires patient protection, last resort application, and evidence-based treatment to mitigate harms.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.2K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
666
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
595
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.4K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.2K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
928